title: Fenofibrate monotherapy-induced rhabdomyolysis in a patient with type-2 diabetes.
authors.forename: Ramazan
authors.initials: R
authors.lastname: Cetinkaya
authors.forename: Abdullah
authors.initials: A
authors.lastname: Uyanik
authors.forename: Rahsan
authors.initials: R
authors.lastname: Yildirim
authors.forename: Yusuf
authors.initials: Y
authors.lastname: Bilen
authors.forename: Mustafa
authors.initials: M
authors.lastname: Keles
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D005260:Female; D011345:Fenofibrate / Q000009:adverse effects*; D006801:Humans; D006875:Hydrotherapy; D006949:Hyperlipidemias / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D008875:Middle Aged; D012206:Rhabdomyolysis / Q000139:chemically induced*; D012307:Risk Factors
chemical_list: D000960:Hypolipidemic Agents; D011345:Fenofibrate